Tumor-associated macrophages in Frount-deficient mice also displayed lower expression of the activation markers CD80, CD86 and MHC class II, as well as M2 macrophage marker CD206, compared to those in control mice (Fig. 4b). This evidence concerns the gene CD86 and neoplasm.